Allogeneic stem cell transplantation (SCT) in HIV-infected subjects with hematological malignancies considerably reduces the viral reservoir. However, because antiretroviral treatment (cART) is maintained in these patients, it is difficult to infer the dynamics of viral rebound if cART is withdrawn. Herein, we explore the mice viral outgrowth approach (mVOA) as a potential tool to predict early viral rebound after cART discontinuation needed to evaluate the success of any eradication strategy.
Blood leukapheresis was collected from 4 subjects that had undergone SCT within the IciStem cohort, and 2 ‘control’ HIV-infected subjects who did not receive allotransplants, all of them on cART. Purified CD4[sup]+[/sup] T cells were transferred to 5 immunosupressed NSG mice per patient. Mouse health condition as well as human cell engraftment, T-cell subpopulation and T-cell activation were monitored. We quantified HIV RNA in mouse plasma, as well as total HIV-DNA on peripheral blood cells during the follow up and in spleen upon animal euthanasia. All procedures performed were reviewed and approved by the correspondent Ethical Committees and according to the national and European legislations.
We transferred 10-50 million CD4+ T cells per mouse. A total of five mice were used per study subject, 76% of them completing the follow up. Just one week post-infusion, we detected up to 104 HIV RNA copies/mL in the plasma of mice to which cells from control subjects had been transferred. Total HIV DNA was also detected in peripheral blood cells between weeks 1 and 3 (105 copies/million cells). Conversely, after 13 weeks of follow up, no HIV RNA or DNA was detected in either plasma or peripheral blood cells of mice to which CD4+ T cells from transplanted subjects had been transferred. These mice achieved a human lymphocyte engraftment over 40%, with human CD4+ T cells activation levels over 50% in all cases. Finally, total HIV DNA was detected in all spleens of mice from ‘control’ cases (106 copies per million cells), but not in the ones infused with cells from allotransplanted cases.
Mice qVOA might become a feasible tool to anticipate in vivo viral rebound dynamics after a substantial reduction of the HIV latent reservoir in eradication strategies, such as allogeneic stem cell transplantation. Compared with other assays, mVOA might reflect more physiological conditions of viral reactivation.